Profile of veliparib and its potential in the treatment of solid tumors
نویسنده
چکیده
Inhibition of poly(ADP-ribose) polymerase (PARP) is an attractive therapeutic strategy because of the importance of this pathway in restoring DNA damage. Small-molecule inhibitors of PARP appear most effective when used to treat tumors with underlying defects in DNA repair, or when combined with DNA-damaging agents. Veliparib is one of several recently developed oral inhibitors of PARP currently in clinical trials. This review summarizes the pharmacology, mechanisms of action, toxicity, and activity of veliparib seen in clinical trials to date. Also discussed are proposed mechanisms of resistance, potential biomarkers of activity, and issues regarding patient selection and combination therapies that may optimize use of this exciting new agent.
منابع مشابه
Phase 1 dose‐escalation study of single‐agent veliparib in Japanese patients with advanced solid tumors
Veliparib (ABT-888) is a potent, orally bioavailable poly(ADP-ribose) polymerase-1 and -2 inhibitor. This phase 1 study evaluated the tolerability, pharmacokinetic profile, safety, and preliminary antitumor activity of single-agent veliparib in Japanese patients with advanced solid tumors. Eligible patients were assigned to treatment with veliparib at 200 or 400 mg dose; veliparib was self-admi...
متن کاملدرمان سرطان با امواج فراصوت متمرکز با شدت بالا(HIFU)
Background and Purpose: Cancer is a major public health problem worldwide and is one of the most leading causes of death in the world. The number of cancer survivors is increasing because of early detection, new treatment methods and growth of the population. Also, the extensive researches continue to achieve the best practical treatment. Hyperthermia by High-Intensity Focused Ultrasound (HI...
متن کاملMain Determinants of Severe Neutropenia in Patients with Solid Tumors Receiving Adjuvant Chemotherapy
Background:Chemotherapy-induced neutropenia as a major toxicity of systemic chemotherapy is commonly associated with substantial mortality and morbidity, and thus identifying its determinants is necessary. This study was undertaken to identify main risk factors of severe neutropenia following adjuvant chemotherapy treatment in a community-based population of patients with cancer in Semnan, I...
متن کاملبررسی سونوگرافیک تومورهای سولید کلیه
ABSTRACT: Solid tumors of adult kidney are the most malignant tumors of human body After bladder tumors, they are the commonest solid tumors of urinary tract. There is a tendency to study these lesions by modalities other than sonography and for this reason there are some doubts in studying these tumors by sonography. For resolving these doubts , the first step is to reveal the different son...
متن کاملA phase I study of veliparib in combination with metronomic cyclophosphamide in adults with refractory solid tumors and lymphomas.
PURPOSE Oral administration of the alkylating agent cyclophosphamide at low doses, metronomic dosing, is well tolerated, with efficacy in multiple tumor types. PARP inhibition potentiates effects of cyclophosphamide in preclinical models. We conducted a phase I trial of the PARP inhibitor veliparib and metronomic cyclophosphamide in patients with refractory solid tumors and lymphoid malignancie...
متن کامل